BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35943555)

  • 1. Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis.
    Hermesse J; Pleyers C; Gennigens C; De Cuypere M; Lovinfosse P; Seidel Statistician L; Coucke P; Kridelka F
    Strahlenther Onkol; 2023 Feb; 199(2):141-148. PubMed ID: 35943555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
    Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic.
    Stevens MJ; Ko F; Martland J; Brown R; Bell L; Atyeo J; Yim J
    Radiat Oncol; 2023 Mar; 18(1):54. PubMed ID: 36941643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
    le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
    Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
    Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S
    Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experience.
    Ogorodniitchouk O; Aunier J; Bousarsar A; Lahmamssi C; Sotton S; Ouaz H; Moreno-Acosta P; Moslemi D; Molekzadehmoghani M; Langrand-Escure J; Magne N; Vallard A
    Cancer Radiother; 2021 Jul; 25(5):463-468. PubMed ID: 34023215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data.
    Kashid SR; Gurram L; Pullan S; Chopra S; Mittal P; Ghadi Y; Dheera A; Scaria L; Kohle S; Kadam S; Ghosh J; Rath S; Gupta S; Mahantshetty U
    Brachytherapy; 2024 Apr; ():. PubMed ID: 38641455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
    Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
    Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Application Multifractionated Image Guided Adaptive High-Dose-Rate Brachytherapy for Cervical Cancer: Dosimetric and Clinical Outcomes.
    Mahantshetty U; Gurram L; Bushra S; Ghadi Y; Aravindakshan D; Paul J; Hande V; Pilar A; Chopra S; Ghosh J; Shylasree TS; Popat P; Sable N; Maheswari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):826-834. PubMed ID: 34146636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
    Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
    Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
    Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
    Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer-A Single Institution Retrospective Study.
    Faye MD; Petruccelli Araujo M; Wissing MD; Alrabiah K; Gilbert L; Zeng X; Souhami L; Alfieri J
    Curr Oncol; 2023 May; 30(5):4966-4978. PubMed ID: 37232833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
    Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
    Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
    Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
    Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
    Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
    Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer.
    Zhao Z; Zhang N; Liu Y; Wu N; Mao Z; Yang W; Cheng G
    J Contemp Brachytherapy; 2020 Jun; 12(3):252-259. PubMed ID: 32695197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.